Rituximab in ANCA-associated vasculitis: a revolution?

被引：14
|
作者：
Tervaert, Jan Willem Cohen [1 ]
机构：
[1] Maastricht Univ Med Ctr, Dept Internal Med, Div Clin & Expt Immunol, Maastricht, Netherlands
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2011年 / 26卷 / 10期
关键词：
ANCA; pathophysiology; rituximab; therapy; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; WEGENERS-GRANULOMATOSIS; SYSTEMIC VASCULITIS; RENAL VASCULITIS; ANIMAL-MODEL; GLOMERULONEPHRITIS; CYCLOPHOSPHAMIDE; AAV; RTX; ACTIVATION;
D O I：
10.1093/ndt/gfr507
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：3077 / 3079
页数：3
相关论文
共 50 条
  • [11] ANCA-associated vasculitis
    Yates, Max
    Watts, Richard
    CLINICAL MEDICINE, 2017, 17 (01) : 60 - 64
  • [12] Impact of rituximab trials on the treatment of ANCA-associated vasculitis
    Alberici, Federico
    Jayne, David R. W.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (06) : 1151 - 1159
  • [13] Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
    Guillevin, L.
    Pagnoux, C.
    Karras, A.
    Khouatra, C.
    Aumaitre, O.
    Cohen, P.
    Maurier, F.
    Decaux, O.
    Ninet, J.
    Gobert, P.
    Quemeneur, T.
    Blanchard-Delaunay, C.
    Godmer, P.
    Puechal, X.
    Carron, P. -L.
    Hatron, P. -Y.
    Limal, N.
    Hamidou, M.
    Ducret, M.
    Daugas, E.
    Papo, T.
    Bonnotte, B.
    Mahr, A.
    Ravaud, P.
    Mouthon, L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (19) : 1771 - 1780
  • [14] Rituximab for ANCA-associated vasculitis in the setting of severe infection
    Gregersen, J. W.
    Chaudhry, A.
    Jayne, D. R. W.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (03) : 207 - 210
  • [15] Rituximab for ANCA-associated vasculitis: The experience in the United States
    Clain, Jeremy M.
    Specks, Ulrich
    PRESSE MEDICALE, 2013, 42 (04): : 530 - 532
  • [16] Avacopan for the treatment of ANCA-associated vasculitis
    Osman, Mohammed
    Cohen Tervaert, Jan Willem
    Pagnoux, Christian
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (07) : 717 - 726
  • [17] Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
    Stone, John H.
    Merkel, Peter A.
    Spiera, Robert
    Seo, Philip
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    Clair, E. William St.
    Turkiewicz, Anthony
    Tchao, Nadia K.
    Webber, Lisa
    Ding, Linna
    Sejismundo, Lourdes P.
    Mieras, Kathleen
    Weitzenkamp, David
    Ikle, David
    Seyfert-Margolis, Vicki
    Mueller, Mark
    Brunetta, Paul
    Allen, Nancy B.
    Fervenza, Fernando C.
    Geetha, Duvuru
    Keogh, Karina A.
    Kissin, Eugene Y.
    Monach, Paul A.
    Peikert, Tobias
    Stegeman, Coen
    Ytterberg, Steven R.
    Specks, Ulrich
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03) : 221 - 232
  • [18] Advances in Therapy for ANCA-Associated Vasculitis
    Geetha, Duvuru
    Seo, Philip
    CURRENT RHEUMATOLOGY REPORTS, 2012, 14 (06) : 509 - 515
  • [19] Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course
    Tariq, Anam
    Akenroye, Ayobami
    Azar, Antoine
    Seo, Philip
    Geetha, Duvuru
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2022, 9 (02) : 93 - 99
  • [20] Rituximab in ANCA-Associated Vasculitis: Fad or Fact?
    Fervenza, Fernando C.
    NEPHRON CLINICAL PRACTICE, 2011, 118 (02): : C182 - C188
12345